🇺🇸 FDA
Patent

US 8568714

Lys K endolysin is synergistic with lysostaphin against MRSA

granted A61KA61K38/47A61K38/4886

Quick answer

US patent 8568714 (Lys K endolysin is synergistic with lysostaphin against MRSA) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary of Agriculture
Grant date
Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K38/47, A61K38/4886, A61P, A61P31/04